Pricing Log in Create free account

Eupraxia Pharmaceuticals Inc. (EPRX) vs MapLight Therapeutics, Inc. (MPLT)

Eupraxia Pharmaceuticals Inc. and MapLight Therapeutics, Inc. are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and MapLight Therapeutics, Inc. are of similar size ($446.2M and $445.7M). Across the 10 metrics below, Eupraxia Pharmaceuticals Inc. leads on 5 and MapLight Therapeutics, Inc. on 5.

Valuation

Metric EPRX MPLT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 4.38 1.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (15.41%) (549.48%) (33.15%)
Free cash flow yield (8.72%) (50.06%) (25.50%)

Profitability

Metric EPRX MPLT Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (117.82%) (297.18%) (56.36%)
Return on assets (64.44%) (124.79%) (48.04%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric EPRX MPLT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (35.53%) 82.39% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric EPRX MPLT Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 16.00 16.52 4.72
Net debt to EBITDA 2.11 1.79 0.96

Dividend

Metric EPRX MPLT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EPRX MPLT Biotechnology median
Market cap 446.21m 445.72m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack